Company MetaStat, Inc. Other OTC
Equities
MTST
US59140A2033
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
Novel Diagnostics
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 01/14/01 | |
Frederick Pierce
IRC | Investor Relations Contact | 63 | 01/15/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 01/14/01 | |
Paul Billings
BRD | Director/Board Member | 71 | 24/17/24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 279,904 | 0 | 0 | 98.43 % |
Stock B | 1 | 5,877,383 | 5,785,202 ( 98.43 %) | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-0.09% | 4.21TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.92TCr | |
+11.18% | 2.6TCr | |
-21.95% | 1.89TCr | |
+8.61% | 1.32TCr | |
+24.73% | 1.22TCr | |
+28.31% | 1.22TCr | |
-6.26% | 1.14TCr |